Sumitomo Pharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is April - March.

Millions EUR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 20, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	5,388	1,789	969	2,228	3,558	5,898
Market Cap Growth	285.13%	84.67%	-56.51%	-37.37%	-39.67%	25.11%
Enterprise Value	6,493	3,575	3,270	2,397	4,497	7,137
Last Close Price	13.70	4.52	2.38	5.45	8.55	13.91
PE Ratio	9.01	12.26	-	-	8.51	13.62
PS Ratio	2.19	0.73	0.50	0.58	0.86	1.48
PB Ratio	3.43	1.71	1.01	0.79	0.71	1.18
P/TBV Ratio	-	-	-	-	34.15	37.03
P/FCF Ratio	21.06	36.19	-	92.74	20.09	5.91
P/OCF Ratio	18.62	17.55	-	26.96	15.36	5.65
EV/Sales Ratio	2.61	1.45	1.70	0.62	1.08	1.80
EV/EBITDA Ratio	9.10	15.00	-	-	6.17	12.04
EV/EBIT Ratio	10.91	44.43	-	-	10.12	17.06
EV/FCF Ratio	25.38	72.31	-	99.75	25.39	7.15
Debt / Equity Ratio	0.90	1.85	2.74	0.85	0.42	0.45
Debt / EBITDA Ratio	1.99	8.14	-	-	2.89	3.78
Debt / FCF Ratio	5.50	39.27	-	99.82	11.91	2.24
Net Debt / Equity Ratio	0.70	1.72	2.55	0.50	0.12	0.15
Net Debt / EBITDA Ratio	1.55	7.55	-1.26	-2.38	0.83	1.26
Net Debt / FCF Ratio	4.28	36.38	-1.58	58.47	3.41	0.75
Asset Turnover	0.54	0.48	0.31	0.46	0.43	0.40
Inventory Turnover	1.95	1.46	1.21	1.85	1.64	1.61
Quick Ratio	0.91	0.43	0.25	0.65	1.27	1.19
Current Ratio	1.40	1.07	0.52	1.03	1.79	1.65
Return on Equity (ROE)	48.39%	14.52%	-111.89%	-17.90%	6.14%	5.75%
Return on Assets (ROA)	8.13%	0.99%	-21.74%	-6.46%	2.86%	2.65%
Return on Invested Capital (ROIC)	22.11%	2.56%	-60.99%	-18.52%	3.91%	3.23%
Return on Capital Employed (ROCE)	18.00%	2.60%	-90.60%	-16.50%	5.80%	5.30%
Earnings Yield	11.10%	8.16%	-199.19%	-23.15%	11.75%	7.34%
FCF Yield	4.75%	2.76%	-159.79%	1.08%	4.98%	16.92%
Dividend Yield	-	-	-	2.67%	2.43%	1.55%
Payout Ratio	0.00%	0.01%	-	-	19.72%	19.78%
Total Shareholder Return	-	-	-	2.67%	2.43%	1.55%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.